151 related articles for article (PubMed ID: 20931434)
41. Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats.
Zhong Z; Froh M; Lehnert M; Schoonhoven R; Yang L; Lind H; Lemasters JJ; Thurman RG
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1004-13. PubMed ID: 12791596
[TBL] [Abstract][Full Text] [Related]
42. Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats.
Oztürk H; Oztürk H; Dokucu AI; Otcu S
Acta Gastroenterol Belg; 2006; 69(2):197-202. PubMed ID: 16929615
[TBL] [Abstract][Full Text] [Related]
43. The effects of chitosan and low dose dexamethasone on extrahepatic cholestasis after bile duct ligation in Wistar rats.
Olteanu D; Filip A; Mureşan A; Nagy A; Tabaran F; Moldovan R; Decea N; Catoi C; Clichici S
Acta Physiol Hung; 2012 Mar; 99(1):61-73. PubMed ID: 22425809
[TBL] [Abstract][Full Text] [Related]
44. The effect of alpha‑lipoic acid on oxidative parameters and liver injury in rats with obstructive jaundice.
Atalay E; Ozdemir MT; Tur BK; Erdogdu HI; Sisman P
Bratisl Lek Listy; 2019; 120(11):843-848. PubMed ID: 31747765
[TBL] [Abstract][Full Text] [Related]
45. Interferon-alpha preserves erythrocyte and hepatocyte ATPase activities from liver damage induced by prolonged bile duct ligation in the rat.
Muriel P
J Appl Toxicol; 1995; 15(6):449-53. PubMed ID: 8603932
[TBL] [Abstract][Full Text] [Related]
46. Antioxidants vitamin E and C attenuate hepatic fibrosis in biliary-obstructed rats.
Soylu AR; Aydogdu N; Basaran UN; Altaner S; Tarcin O; Gedik N; Umit H; Tezel A; Dokmeci G; Baloglu H; Ture M; Kutlu K; Kaymak K
World J Gastroenterol; 2006 Nov; 12(42):6835-41. PubMed ID: 17106933
[TBL] [Abstract][Full Text] [Related]
47. Hepatoprotective effects of parsley (Petroselinum Crispum) extract in rats with bile duct ligation.
Ede S; Özbeyli D; Erdoğan Ö; Çevik Ö; Kanpalta F; Ercan F; Yanardağ R; Saçan Ö; Ertik O; Yüksel M; Şener G
Arab J Gastroenterol; 2023 Feb; 24(1):45-51. PubMed ID: 36379859
[TBL] [Abstract][Full Text] [Related]
48. Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression.
Fiebiger WC; Scheithauer W; Traub T; Kurtaran A; Gedlicka C; Kornek GV; Virgolini I; Raderer M
Scand J Gastroenterol; 2002 Feb; 37(2):222-5. PubMed ID: 11843061
[TBL] [Abstract][Full Text] [Related]
49. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc.
Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS
Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650
[TBL] [Abstract][Full Text] [Related]
50. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats.
Lee TY; Chang HH; Chen JH; Hsueh ML; Kuo JJ
J Ethnopharmacol; 2007 Jan; 109(2):318-24. PubMed ID: 16989967
[TBL] [Abstract][Full Text] [Related]
51. Bone marrow-derived mesenchymal stem cells effectively regenerate fibrotic liver in bile duct ligation rat model.
Mohamed HE; Elswefy SE; Rashed LA; Younis NN; Shaheen MA; Ghanim AM
Exp Biol Med (Maywood); 2016 Mar; 241(6):581-91. PubMed ID: 26811102
[TBL] [Abstract][Full Text] [Related]
52. Role of nitric oxide and KATP channel in the protective effect mediated by nicorandil in bile duct ligation-induced liver fibrosis in rats.
Mohamed YS; Ahmed LA; Salem HA; Agha AM
Biochem Pharmacol; 2018 May; 151():135-142. PubMed ID: 29522711
[TBL] [Abstract][Full Text] [Related]
53. Effects of Myrtus communis extract treatment in bile duct ligated rats.
Sen A; Ozkan S; Recebova K; Cevik O; Ercan F; Kervancıoglu Demirci E; Bitis L; Sener G
J Surg Res; 2016 Oct; 205(2):359-367. PubMed ID: 27664884
[TBL] [Abstract][Full Text] [Related]
54. The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat.
Matono T; Koda M; Tokunaga S; Sugihara T; Ueki M; Murawaki Y
Int J Mol Med; 2010 Jun; 25(6):875-82. PubMed ID: 20428791
[TBL] [Abstract][Full Text] [Related]
55. Protective effect of IGF-1 on experimental liver cirrhosis-induced common bile duct ligation.
Cantürk NZ; Cantürk Z; Ozden M; Dalçik H; Yardimoglu M; Tülübas F
Hepatogastroenterology; 2003; 50(54):2061-6. PubMed ID: 14696465
[TBL] [Abstract][Full Text] [Related]
56. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
[TBL] [Abstract][Full Text] [Related]
57. Oxidative-stress-related changes in the livers of bile-duct-ligated rats.
Huang YT; Hsu YC; Chen CJ; Liu CT; Wei YH
J Biomed Sci; 2003; 10(2):170-8. PubMed ID: 12595753
[TBL] [Abstract][Full Text] [Related]
58. [Somatuline(R) Autogel(R), a new formulation of lanreotide for the treatment of acromegalic patients].
Caron P
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 3):2S19-24. PubMed ID: 12037499
[TBL] [Abstract][Full Text] [Related]
59. The Kampo medicine "Daikenchuto (TU-100)" prevents bacterial translocation and hepatic fibrosis in a rat model of biliary atresia.
Yada K; Ishibashi H; Mori H; Morine Y; Zhu C; Feng R; Kono T; Shimada M
Surgery; 2016 Jun; 159(6):1600-1611. PubMed ID: 26994485
[TBL] [Abstract][Full Text] [Related]
60. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats.
Mahmoud MF; Swefy SE; Hasan RA; Ibrahim A
Eur J Pharmacol; 2014 Nov; 742():118-24. PubMed ID: 25179573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
